• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma industry news

phase-i-trials

Serious adverse events rare in healthy volunteers participating in Phase I trials

7 July 2015

A new study has found that less than 1% of 11,000 healthy volunteers who participated in 394 Phase I trials for new drugs experienced serious complications...

acebilustat

Celtaxsys gains US clearance for Phase 2 trial of acebilustat in patients with cystic fibrosis

7 July 2015

Celtaxsys has gained clearance from the US FDA to begin a Phase 2 clinical trial of acebilustat in adult patients with cystic fibrosis (CF) in the US...

s.-aureus

Pfizer begins Phase 2b study of S. aureus vaccine in adults undergoing elective spinal fusion surgery

7 July 2015

The first patients have been enrolled in a Phase 2b clinical trial of Pfizer’s S. aureus vaccine in adults undergoing elective spinal fusion surgery...

migraine

Allergan to acquire exclusive worldwide rights to Merck’s CGRP migraine development programme

7 July 2015

Allergan is to acquire exclusive worldwide rights to Merck's CGRP receptor antagonists, which are being developed for the treatment of migraine...

A scanning electron micrograph of Mycobacterium tuberculosis bacteria. CREDIT: Stewart Cole/EPFL

Over-the-counter antacid lansoprazole could be an effective anti-tuberculosis drug

7 July 2015

Testing thousands of approved drugs, EPFL scientists have found that an over-the-counter antacid, lansoprazole, may be an effective anti-tuberculosis drug...

west-nile-virus

Vaccine for West Nile virus enters human clinical trials

7 July 2015

A new investigational vaccine designed to protect against West Nile Virus infection is being tested in a Phase 1 clinical trial...

imvamune-smallpox

Bavarian Nordic receives bulk order for Imvamune smallpox vaccine

7 July 2015

BARDA, a division of the US Department of Health & Human Services, has ordered a bulk supply of Bavarian Nordic’s Imvamune non-replicating smallpox vaccine...

afatinib

Phase III data show significant overall survival benefit of afatinib compared to erlotinib in patients with SCC

6 July 2015

Results from the LUX-Lung 8 Trial demonstrate that afatinib resulted in superior progression-free survival and overall survival compared to erlotinib...

dementia

Patients with dementia not getting enough help from health and social care services, say GPs

6 July 2015

Over three quarters of UK GPs think their patients with dementia rely on family as they do not get enough help from health and social care services...

allergan-dry-eye

Allergan to acquire Oculeve dry eye disease development programmes

6 July 2015

Allergan is to acquire Oculeve. The acquisition will add novel, complementary dry eye development programmes to Allergan's portfolio...

rabies

World Zoonosis Day: Now is the time to take the bite out of rabies

6 July 2015

Despite being preventable thanks to vaccines, over 60,000 people die from rabies each year making it one of the world’s most deadly infectious diseases...

cetuximab

Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

6 July 2015

Results from a study on the efficacy of cetuximab plus FOLFOX chemo as second-line treatment for patients with mCRC were presented at the ESMO 2015 congress...

 

Webinar: Increasing throughput and sensitivity of LC-MS assaysWATCH LIVE
+ +